JamesChung-YinYangMD

General Surgery • Bethesda, MD

Assistant Professor, Surgery, Uniformed Services Hebert SOM

Join to view full profile

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yang's full profile

Already have an account?

Office
9000 Rockville Pike
Bldg 10a Crc, Rm 3-5952
Bethesda, MD 20892
Phone+1 240-760-6223

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1984 - 1986
University of California (San Diego) Medical CenterResidency, Surgery, 1978 - 1984
University of California San Diego School of MedicineClass of 1978

Certifications & Licensure

CA State Medical License 1980 - 2025

Clinical Trials

CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma Start of enrollment: 2009 Feb 17
Completed
Phase 1, Phase 2
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer Start of enrollment: 2013 Oct 24
Completed
Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2014 Oct 23
Recruiting
Phase 2
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers Start of enrollment: 2017 Apr 06
Recruiting
Phase 1, Phase 2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Start of enrollment: 2017 Sep 21
Recruiting
Phase 1, Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer Start of enrollment: 2018 Sep 06
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

6 citations
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results.
Maria Parkhurst, Stephanie L Goff, Frank J Lowery, Rachel K Beyer, Hyunmi Halas
Nature Medicine. 2024-09-01
1 citations
Lifileucel: FDA-approved T-cell therapy for melanoma.
Mei Li M Kwong, James C Yang
The Oncologist. 2024-08-05
4 citations
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
Lekha Mikkilineni, Danielle A Natrakul, Norris Lam, Elisabet E Manasanch, Jennifer Mann
Molecular Therapy. 2024-02-07